CN Patent
CN102232949A — 提高药物溶出度的组合物及其制备方法
Assigned to 孙远 · Expires 2011-11-09 · 15y expired
What this patent protects
本发明涉及提高药物溶出度的组合物及其制备方法,特别是一种含有普拉格雷及其盐的药物组合物及其制备方法,该药物组合物通过采用固体分散体技术、包合物技术或加入表面活性剂提高了普拉格雷及其盐在较高pH值条件下的溶出度。
USPTO Abstract
本发明涉及提高药物溶出度的组合物及其制备方法,特别是一种含有普拉格雷及其盐的药物组合物及其制备方法,该药物组合物通过采用固体分散体技术、包合物技术或加入表面活性剂提高了普拉格雷及其盐在较高pH值条件下的溶出度。
Drugs covered by this patent
- Oxbryta (voxelotor) · Global Blood Theraps
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.